cigb-300
Peptideexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jun 1, 2010 (NCT01639638)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- cigb-300
- cigb-300
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01639625 | Phase 2 | May 1, 2011 | Laboratorio Elea S.A.C.I.F. y A. |
| NCT01639638 | Phase 2/Phase 3 (Phase 3) | Jun 1, 2010 | Laboratorio Elea S.A.C.I.F. y A. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Laboratorio Elea S.A.C.I.F. y A. | For profit | 2 | 2 | 2 | 2010 |
1 organizations
Page 1 / 1